• 1. Operation Management Department, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;
  • 2. President & Dean’s Office, Jintang First People’s Hospital, Jintang, Sichuan 610400, P. R. China;
  • 3. Sichuan University - The Hong Kong Polytechnic University Institute for Disaster Management and Reconstruction, Chengdu, Sichuan 610207, P. R. China;
  • 4. West China School of Nursing / West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;
  • 5. Public Affairs Department, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;
  • 6. Department of Infection, Jintang First People’s Hospital, Jintang, Sichuan 610400, P. R. China;
  • 7. Department of Nursing, Jintang First People’s Hospital, Jintang, Sichuan 610400, P. R. China;
  • 8. Department of Operation Management and Information, Jintang First People’s Hospital, Jintang, Sichuan 610400, P. R. China;
  • 9. Hierarchical Diagnosis and Treatment Office, Jintang First People’s Hospital, Jintang, Sichuan 610400, P. R. China;
  • 10. Department of Research and Teaching, Jintang First People’s Hospital, Jintang, Sichuan 610400, P. R. China;
  • 11. Department of Orthopedics, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P. R. China;
LIU Ming, Email: 1078289717@qq.com
Export PDF Favorites Scan Get Citation

Objective To explore the innovative application and effect of lead-type close medical consortium under the epidemic situation of coronavirus disease 2019 (COVID-19).Methods During the epidemic of COVID-19, Jintang First People’s Hospital implemented a series of innovative countermeasures under the guidance of West China Hospital of Sichuan University, the leading hospital of a lead-type close medical consortium. To verify the implementation effect of the countermeasures, the patient satisfaction questionnaire and medical personnel satisfaction questionnaire were administered in confirmed or suspected COVID-19 patients and anti-epidemic healthcare workers. The relevant health economic indicators were extracted through the hospital information system for descriptive analysis.Results A total of 16 patients were included, including 10 confirmed patients and 6 suspected patients. The median score of patient satisfaction was 66. All patients were cured and discharged. A total of 56 healthcare workers were included, including 18 doctors and 38 nurses, with a median satisfaction score of 81. The average length of hospital stay of patients was 11.00 d, the average hospitalization cost was 5 117.35 yuan; the average drug cost was 1 099.95 yuan, accounted for 21.49%; the average material cost was 38.63 yuan, accounted for 0.75%.Conclusions The innovative application of the lead-type close medical consortium in the treatment of patients with COVID-19 plays an important role in the prevention and control of epidemic, and has achieved remarkable results in patients treatment, patients satisfaction, and hospital management. It is worthy of being widely popularized.

Citation: LI Rongmei, DU Xinwen, FENG Xianqiong, WANG Miao, LUO Chunxia, CHEN Birong, LEI Yuqian, JIANG Guanghui, CHEN Zhuo, LIU Ming. Innovative application and effects of lead-type close medical consortium under the epidemic situation of coronavirus disease 2019. West China Medical Journal, 2021, 36(2): 160-165. doi: 10.7507/1002-0179.202004432 Copy

  • Previous Article

    Safety and quality management of ophthalmic day surgery center under the regular prevention and control for coronavirus disease 2019 epidemic
  • Next Article

    Progress in clinical research related to coronavirus disease 2019